Copyright © 1999 by the European Society of Cardiology.
Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure
a Department of Cardiac Medicine, National Heart and Lung Institute, London, U.K.
b Franz-Volhard-Klinik at Max Delbrück Centrum for Molecular Medicine, Charité, Campus Berlin-Buch, Berlin, Germany
c Department of Biochemistry, Royal Brompton Hospital, London, U.K.
d Department of Applied Pharmacology, National Heart and Lung Institute, London, U.K.
revised December 8, 1998; accepted December 9, 1998
Abstract
Background
Chronic heart failure is one of a number of disorders associated with the development of a wasting syndrome. The precise mechanisms of this remain unknown, but previous studies have suggested a role for immune and neurohormonal factors.
Methods
We aimed to investigate in detail the differences in body composition (dual X-ray absorptiometry) and the relationship to candidate biochemical factors of the immune, neurohormonal and metabolic systems in 15 healthy controls, 36 stable non-cachectic and 18 cachectic patients with chronic heart failure.
Results
Non-cachectic patients showed reduced leg lean tissue (–9·1%,P<0·01) compared to controls. Cachectic patients had significantly reduced lean (–21·0% vs controls, –19·9% vs non-cachectics), fat (–33·0% vs controls, –37·0% vs non-cachectics) and bone tissue (–17·5% vs controls, –15·9% vs non-cachectics) (allP<0·0001). Cachectic patients showed a significantly increased cortisol/dehydroepiandrosterone ratio (+203% vs controls,P<0·0001; +89% vs non-cachectics,P=0·0011) and increased cytokine levels (TNF-
, soluble TNF-receptor 1, interleukin-6). The levels of catabolic hormones and cytokines correlated significantly with reduced muscle and fat tissue content and reduced bone mass.
Conclusion
Peripheral loss of muscle tissue is a general finding in chronic heart failure. The wasting in cardiac cachexia affects all tissue compartments and is significantly related to neurohormonal and immunological abnormalities.
Key Words: Heart failure, cytokines, body composition, cachexia.
f1 Correspondence: Dr Stefan Anker, Department of Cardiac Medicine, National Heart and Lung Institute London, Dovehouse Street, London SW3 6LY, U.K.
f2 Dr Stefan Anker is supported by a Postgraduate Fellowship of the Max Delbrück Centrum, Berlin, Germany.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Al-Najjar, K. M. Goode, J. Zhang, J. G.F. Cleland, and A. L. Clark Red cell distribution width: an inexpensive and powerful prognostic marker in heart failure Eur J Heart Fail, December 1, 2009; 11(12): 1155 - 1162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. H. Sillen, C. M. Speksnijder, R.-M. A. Eterman, P. P. Janssen, S. S. Wagers, E. F. M. Wouters, N. H. M. K. Uszko-Lencer, and M. A. Spruit Effects of Neuromuscular Electrical Stimulation of Muscles of Ambulation in Patients With Chronic Heart Failure or COPD: A Systematic Review of the English-Language Literature Chest, July 1, 2009; 136(1): 44 - 61. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Niessner, P. J. Hohensinner, K. Rychli, S. Neuhold, G. Zorn, B. Richter, M. Hulsmann, R. Berger, D. Mortl, K. Huber, et al. Prognostic value of apoptosis markers in advanced heart failure patients Eur. Heart J., April 1, 2009; 30(7): 789 - 796. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Tracchi, G. Ghigliotti, M. Mura, S. Garibaldi, P. Spallarossa, C. Barisione, V. Boasi, M. Brunelli, L. Corsiglia, A. Barsotti, et al. Increased neutrophil lifespan in patients with congestive heart failure Eur J Heart Fail, April 1, 2009; 11(4): 378 - 385. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Jankowska, J. Jakubaszko, A. Cwynar, J. Majda, B. Ponikowska, D. Kustrzycka-Kratochwil, K. Reczuch, L. Borodulin-Nadzieja, W. Banasiak, P. A. Poole-Wilson, et al. Bone mineral status and bone loss over time in men with chronic systolic heart failure and their clinical and hormonal determinants Eur J Heart Fail, January 1, 2009; 11(1): 28 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. J. Pocock, J. J.V. McMurray, J. Dobson, S. Yusuf, C. B. Granger, E. L. Michelson, J. Ostergren, M. A. Pfeffer, S. D. Solomon, S. D. Anker, et al. Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme Eur. Heart J., November 1, 2008; 29(21): 2641 - 2650. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Toblli, A. Lombrana, P. Duarte, and F. Di Gennaro Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients With Chronic Heart Failure and Renal Insufficiency J. Am. Coll. Cardiol., October 23, 2007; 50(17): 1657 - 1665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. L. Clark, C. Knosalla, E. Birks, M. Loebe, C. H. Davos, S. Tsang, A. Negassa, M. Yacoub, R. Hetzer, A. J.S. Coats, et al. Heart transplantation in heart failure: The prognostic importance of body mass index at time of surgery and subsequent weight changes Eur J Heart Fail, August 1, 2007; 9(8): 839 - 844. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. McEntegart, B. Awede, M. C. Petrie, N. Sattar, F. G. Dunn, N. G. MacFarlane, and J. J.V. McMurray Increase in serum adiponectin concentration in patients with heart failure and cachexia: relationship with leptin, other cytokines, and B-type natriuretic peptide Eur. Heart J., April 2, 2007; (2007) ehm033v1. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Doehner, A. C. Bunck, M. Rauchhaus, S. von Haehling, F. M. Brunkhorst, M. Cicoira, C. Tschope, P. Ponikowski, R. A. Claus, and S. D. Anker Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow Eur. Heart J., April 1, 2007; 28(7): 821 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E Bolton, R. Broekhuizen, A. A Ionescu, L. S Nixon, E. F M Wouters, D. J Shale, and A. M W J Schols Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD Thorax, February 1, 2007; 62(2): 109 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Sandek and M. Rauchhaus Use of bioimpedance analysis in patients with chronic heart failure? Eur J Heart Fail, January 1, 2007; 9(1): 105 - 105. [Full Text] [PDF]
|
|
|
|
|
|
S. Genth-Zotz, S. von Haehling, A. P. Bolger, P. R. Kalra, R. Wensel, A. J.S. Coats, H.-D. Volk, and S. D. Anker The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure Eur J Heart Fail, June 1, 2006; 8(4): 366 - 372. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Jankowska, P. Ponikowski, M. F. Piepoli, W. Banasiak, S. D. Anker, and P. A. Poole-Wilson Autonomic imbalance and immune activation in chronic heart failure - Pathophysiological links Cardiovasc Res, June 1, 2006; 70(3): 434 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cesari, C. Leeuwenburgh, F. Lauretani, G. Onder, S. Bandinelli, C. Maraldi, J. M Guralnik, M. Pahor, and L. Ferrucci Frailty syndrome and skeletal muscle: results from the Invecchiare in Chianti study Am. J. Clinical Nutrition, May 1, 2006; 83(5): 1142 - 1148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Toth and D. E. Matthews Whole-Body Protein Metabolism in Chronic Heart Failure: Relationship to Anabolic and Catabolic Hormones JPEN J Parenter Enteral Nutr, May 1, 2006; 30(3): 194 - 201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E Morley, D. R Thomas, and M.-M. G Wilson Cachexia: pathophysiology and clinical relevance. Am. J. Clinical Nutrition, April 1, 2006; 83(4): 735 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Christ, T. Klima, W. Grimm, H.-H. Mueller, and B. Maisch Prognostic significance of serum cholesterol levels in patients with idiopathic dilated cardiomyopathy Eur. Heart J., March 2, 2006; 27(6): 691 - 699. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Toth, P. A. Ades, M. M. LeWinter, R. P. Tracy, and A. Tchernof Skeletal muscle myofibrillar mRNA expression in heart failure: relationship to local and circulating hormones J Appl Physiol, January 1, 2006; 100(1): 35 - 41. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cesari, S. B. Kritchevsky, B. J. Nicklas, B. W. H. J. Penninx, P. Holvoet, P. Koh-Banerjee, S. R. Cummings, T. B. Harris, A. B. Newman, and M. Pahor Lipoprotein Peroxidation and Mobility Limitation: Results From the Health, Aging, and Body Composition Study Arch Intern Med, October 10, 2005; 165(18): 2148 - 2154. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Jankowska, S. von Haehling, A. Czarny, E. Zaczynska, A. Kus, S. D. Anker, W. Banasiak, and P. Ponikowski Activation of the NF-{kappa}B system in peripheral blood leukocytes from patients with chronic heart failure Eur J Heart Fail, October 1, 2005; 7(6): 984 - 990. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Doehner, M. Rauchhaus, P. Ponikowski, I. F. Godsland, S. von Haehling, D. O. Okonko, F. Leyva, A. J. Proudler, A. J.S. Coats, and S. D. Anker Impaired Insulin Sensitivity as an Independent Risk Factor for Mortality in Patients With Stable Chronic Heart Failure J. Am. Coll. Cardiol., September 20, 2005; 46(6): 1019 - 1026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cesari, S. B Kritchevsky, R. N Baumgartner, H. H Atkinson, B. W. Penninx, L. Lenchik, S. L Palla, W. T Ambrosius, R. P Tracy, and M. Pahor Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study Am. J. Clinical Nutrition, August 1, 2005; 82(2): 428 - 434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. O. Mocelin, V. S. Issa, F. Bacal, G. V. Guimaraes, E. Cunha, and E. A. Bocchi The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: A prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy Eur J Heart Fail, August 1, 2005; 7(5): 869 - 873. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Cabassi, P. Coghi, P. Govoni, E. Barouhiel, E. Speroni, S. Cavazzini, A. M. Cantoni, R. Scandroglio, and E. Fiaccadori Sympathetic Modulation by Carvedilol and Losartan Reduces Angiotensin II-Mediated Lipolysis in Subcutaneous and Visceral Fat J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2888 - 2897. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Toth, D. E. Matthews, P. A. Ades, M. D. Tischler, P. Van Buren, M. Previs, and M. M. LeWinter Skeletal muscle myofibrillar protein metabolism in heart failure: relationship to immune activation and functional capacity Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E685 - E692. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N Wisniacki, W Taylor, M Lye, and J P H Wilding Insulin resistance and inflammatory activation in older patients with systolic and diastolic heart failure Heart, January 1, 2005; 91(1): 32 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Li, D. Gavrila, X. Liu, L. Wang, S. Gunnlaugsson, L. L. Stoll, M. L. McCormick, C. D. Sigmund, C. Tang, and N. L. Weintraub Ghrelin Inhibits Proinflammatory Responses and Nuclear Factor-{kappa}B Activation in Human Endothelial Cells Circulation, May 11, 2004; 109(18): 2221 - 2226. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Cesari, B. W. J. H. Penninx, M. Pahor, F. Lauretani, A. M. Corsi, G. R. Williams, J. M. Guralnik, and L. Ferrucci Inflammatory Markers and Physical Performance in Older Persons: The InCHIANTI Study J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2004; 59(3): M242 - M248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Cesari, B. W. J. H. Penninx, F. Lauretani, C. R. Russo, C. Carter, S. Bandinelli, H. Atkinson, G. Onder, M. Pahor, and L. Ferrucci Hemoglobin Levels and Skeletal Muscle: Results From the InCHIANTI Study J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2004; 59(3): M249 - M254. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Gielen, V. Adams, S. Mobius-Winkler, A. Linke, S. Erbs, J. Yu, W. Kempf, A. Schubert, G. Schuler, and R. Hambrecht Anti-inflammatory effects of exercise training in the skeletal muscle of patients with chronic heart failure J. Am. Coll. Cardiol., September 3, 2003; 42(5): 861 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Murray and G. L. Freeman Proinflammatory Cytokines: Predictors of a Failing Heart? Circulation, March 25, 2003; 107(11): 1460 - 1462. [Full Text] [PDF]
|
|
|
|
|
|
P A Henriksen and D E Newby Therapeutic inhibition of tumour necrosis factor {alpha} in patients with heart failure: cooling an inflamed heart Heart, January 1, 2003; 89(1): 14 - 18. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Radzewitz, E. Miche, G. Herrmann, M. Nowak, U. Montanus, U. Adam, Y. Stockmann, and M. Barth Exercise and muscle strength training and their effect on quality of life in patients with chronic heart failure Eur J Heart Fail, October 1, 2002; 4(5): 627 - 634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Poole-Wilson Death or repair of the myocyte in chronic heart failure J. Am. Coll. Cardiol., September 18, 2002; 40(6): 1104 - 1105. [Full Text] [PDF]
|
|
|
|
|
|
M. Visser, M. Pahor, D. R. Taaffe, B. H. Goodpaster, E. M. Simonsick, A. B. Newman, M. Nevitt, and T. B. Harris Relationship of Interleukin-6 and Tumor Necrosis Factor-{alpha} With Muscle Mass and Muscle Strength in Elderly Men and Women: The Health ABC Study J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2002; 57(5): M326 - 332. [Abstract] [Full Text]
|
|
|
|
|
|
R. Hambrecht, P. C. Schulze, S. Gielen, A. Linke, S. Mobius-Winkler, J. Yu, J.u. Kratzsch, G. Baldauf, M. W. Busse, A. Schubert, et al. Reduction of insulin-like growth factor-I expression in the skeletal muscle of noncachectic patients with chronic heart failure J. Am. Coll. Cardiol., April 3, 2002; 39(7): 1175 - 1181. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R Sharma and S.D Anker From tissue wasting to cachexia: changes in peripheral blood flow and skeletal musculature Eur. Heart J. Suppl., April 1, 2002; 4(suppl_D): D12 - D17. [Abstract] [PDF]
|
|
|
|
|
|
A. P. Maxwell, H. Y. Ong, and D. P. Nicholls Influence of progressive renal dysfunction in chronic heart failure Eur J Heart Fail, March 1, 2002; 4(2): 125 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Anker, M. Volterrani, C.-D. Pflaum, C. J. Strasburger, K. J. Osterziel, W. Doehner, M. B. Ranke, P. A. Poole-Wilson, A. Giustina, R. Dietz, et al. Acquired growth hormone resistance in patients with chronic heart failure: implications for therapy with growth hormone J. Am. Coll. Cardiol., August 1, 2001; 38(2): 443 - 452. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Akner and T. Cederholm Treatment of protein-energy malnutrition in chronic nonmalignant disorders Am. J. Clinical Nutrition, July 1, 2001; 74(1): 6 - 24. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. F. Osman, M. R. Mehra, C. J. Lavie, and R. V. Milani Reply J. Am. Coll. Cardiol., June 1, 2001; 37(7): 2010 - 2011. [Full Text] [PDF]
|
|
|
|
|
|
A.Q. Adigun and A.A. L. Ajayi The effects of enalapril-digoxin-diuretic combination therapy on nutritional and anthropometric indices in chronic congestive heart failure: preliminary findings in cardiac cachexia Eur J Heart Fail, June 1, 2001; 3(3): 359 - 363. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rauchhaus, W. Doehner, D. P. Francis, C. Davos, M. Kemp, C. Liebenthal, J. Niebauer, J. Hooper, H.-D. Volk, A. J. S. Coats, et al. Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart Failure Circulation, December 19, 2000; 102(25): 3060 - 3067. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Doehner and S.D. Anker TNF-{alpha} system in CHF Eur. Heart J., May 1, 2000; 21(9): 782 - 782. [PDF]
|
|